首页 > 最新文献

Biomarkers in medicine最新文献

英文 中文
Interaction between coagulation and inflammatory system in liver disease: re-focus on hematological markers. 肝病中凝血和炎症系统之间的相互作用:重新关注血液标记物。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-09-04 DOI: 10.1080/17520363.2024.2395245
Liuyi Lu, Chunling Zhu, Dongyi Zhou, Siting Li, Liling Yi, Shangmou Wei, Qiliu Peng

Aim: This study uses blood routine, coagulation and biochemical indicators to explore the relationship between the hematological parameters of patients with various types of liver diseases.Methods: The Kruskal-Wallis, Chi-squared and Fisher exact tests were used to compare the hematological parameters and clinical characteristics of three groups of patients with different degrees of liver disease. Spearman correlation analysis is used to analyze the correlation between two continuous variables. The logistic regression model evaluated the odds ratio between variables and disease changes. Receiver operating characteristic curve analysis was used to understand the predictive value of each index in relation to the progress of liver disease.Results: There are differences in inflammation and coagulation profiles among different types of liver diseases and there is a correlation between them. In addition to the traditional marker α-fetoprotein, the inflammatory marker c-reactive protein and the coagulation marker D-dimer also have good diagnostic value for liver injury.Conclusion: The coagulation and inflammation systems interact, are connected and play essential roles in the liver.

目的:本研究利用血常规、凝血和生化指标探讨不同类型肝病患者血液学指标之间的关系:采用 Kruskal-Wallis、Chi-squared 和 Fisher 精确检验比较三组不同程度肝病患者的血液学指标和临床特征。斯皮尔曼相关分析用于分析两个连续变量之间的相关性。逻辑回归模型评估了变量与疾病变化之间的几率比例。采用接收者操作特征曲线分析法了解各指标对肝病进展的预测价值:结果:不同类型肝病的炎症和凝血特征存在差异,且两者之间存在相关性。除了传统的标志物α-甲胎蛋白外,炎症标志物c反应蛋白和凝血标志物D-二聚体对肝损伤也有很好的诊断价值:结论:凝血系统和炎症系统相互作用、相互联系,在肝脏中发挥着重要作用。
{"title":"Interaction between coagulation and inflammatory system in liver disease: re-focus on hematological markers.","authors":"Liuyi Lu, Chunling Zhu, Dongyi Zhou, Siting Li, Liling Yi, Shangmou Wei, Qiliu Peng","doi":"10.1080/17520363.2024.2395245","DOIUrl":"10.1080/17520363.2024.2395245","url":null,"abstract":"<p><p><b>Aim:</b> This study uses blood routine, coagulation and biochemical indicators to explore the relationship between the hematological parameters of patients with various types of liver diseases.<b>Methods:</b> The Kruskal-Wallis, Chi-squared and Fisher exact tests were used to compare the hematological parameters and clinical characteristics of three groups of patients with different degrees of liver disease. Spearman correlation analysis is used to analyze the correlation between two continuous variables. The logistic regression model evaluated the odds ratio between variables and disease changes. Receiver operating characteristic curve analysis was used to understand the predictive value of each index in relation to the progress of liver disease.<b>Results:</b> There are differences in inflammation and coagulation profiles among different types of liver diseases and there is a correlation between them. In addition to the traditional marker α-fetoprotein, the inflammatory marker c-reactive protein and the coagulation marker D-dimer also have good diagnostic value for liver injury.<b>Conclusion:</b> The coagulation and inflammation systems interact, are connected and play essential roles in the liver.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"813-822"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between NT-proBNP levels and existing/de novo QRS fragmentation in patients with myocardial infarction. 心肌梗死患者的 NT-proBNP 水平与现有/新生 QRS 分段之间的关系。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-05-24 DOI: 10.1080/17520363.2024.2345584
Hamza Sunman, Engin Algül, Muhammet Dural, Muhammet Erzurum, Faruk Aydınyılmaz, Tolga Han Efe, Tolga Çimen

Aim: to assess the evolution of fragmented QRS (fQRS) and NT-proBNP levels during myocardial infarction (MI).Methods: Among 511 patients, 205 (40.1%) had fQRS, with 54 (26.3%) developing de novo fragmentation during hospitalization.Results: NT-proBNP levels were significantly higher in the fQRS+ group compared with the fQRS- group (1555 vs. 796 pg/ml, p < 0.001). NT-proBNP levels were higher in patients with de novo fragmentation than in those without (2852 vs. 1370 pg/ml, p = 0.011). The incidence of major adverse cardiovascular events was notably higher in fQRS+ patients compared with fQRS- patients (p = 0.001).Conclusion: In acute MI, there was a significant association between fQRS and NT-proBNP levels, with higher NT-proBNP levels observed in those with de novo fQRS compared with those without.

目的:评估心肌梗死(MI)期间片段QRS(fQRS)和NT-proBNP水平的演变情况:在511名患者中,有205人(40.1%)患有FQRS,其中54人(26.3%)在住院期间出现了新的片段:NT-proBNP水平在fQRS+组明显高于fQRS-组(1555 pg/ml vs. 796 pg/ml, p 结论:在急性心肌梗死中,NT-proBNP水平明显高于fQRS-组:在急性心肌梗死患者中,fQRS 与 NT-proBNP 水平之间存在显著关联,与无 fQRS 的患者相比,有新生 fQRS 的患者 NT-proBNP 水平更高。
{"title":"Relationship between NT-proBNP levels and existing/<i>de novo</i> QRS fragmentation in patients with myocardial infarction.","authors":"Hamza Sunman, Engin Algül, Muhammet Dural, Muhammet Erzurum, Faruk Aydınyılmaz, Tolga Han Efe, Tolga Çimen","doi":"10.1080/17520363.2024.2345584","DOIUrl":"https://doi.org/10.1080/17520363.2024.2345584","url":null,"abstract":"<p><p><b>Aim:</b> to assess the evolution of fragmented QRS (fQRS) and NT-proBNP levels during myocardial infarction (MI).<b>Methods:</b> Among 511 patients, 205 (40.1%) had fQRS, with 54 (26.3%) developing de novo fragmentation during hospitalization.<b>Results:</b> NT-proBNP levels were significantly higher in the fQRS+ group compared with the fQRS- group (1555 vs. 796 pg/ml, p < 0.001). NT-proBNP levels were higher in patients with de novo fragmentation than in those without (2852 vs. 1370 pg/ml, p = 0.011). The incidence of major adverse cardiovascular events was notably higher in fQRS+ patients compared with fQRS- patients (p = 0.001).<b>Conclusion:</b> In acute MI, there was a significant association between fQRS and NT-proBNP levels, with higher NT-proBNP levels observed in those with de novo fQRS compared with those without.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"18 10-12","pages":"535-544"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aurora-B: a novel biomarker in the invasion and metastasis of osteosarcoma. 极光-B:骨肉瘤侵袭和转移的新型生物标记物
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-07-29 DOI: 10.1080/17520363.2024.2366160
Siping Long, Yanxin Zhong, Jiaming Liu

Osteosarcoma (OS), a primary human malignant tumor that affects the bones, mostly arises in children and adolescents. Even though surgical resection followed by radiotherapy and chemotherapy has improved the survival rate up to 60%, the long-term positive effect for most patients with OS is not satisfactory. Hence, elucidating the specific mechanisms involved in the pathogenesis of OS is particularly important. Aurora-B, a serine/threonine kinase, plays a crucial role in centrosome regulation, spindle formation and chromosomal separation during mitosis. It has been found that Aurora-B overexpression is related to the occurrence and development of several malignant tumors, including OS. This article summarizes the role of Aurora-B in the invasion and metastasis of OS.

骨肉瘤(Osteosarcoma,OS)是一种影响骨骼的原发性人类恶性肿瘤,多发于儿童和青少年。尽管手术切除后再进行放疗和化疗可将生存率提高到 60%,但大多数骨肉瘤患者的长期疗效并不令人满意。因此,阐明OS发病的具体机制尤为重要。Aurora-B是一种丝氨酸/苏氨酸激酶,在有丝分裂过程中的中心体调节、纺锤体形成和染色体分离中发挥着至关重要的作用。研究发现,Aurora-B 的过表达与包括 OS 在内的多种恶性肿瘤的发生和发展有关。本文总结了Aurora-B在OS的侵袭和转移中的作用。
{"title":"Aurora-B: a novel biomarker in the invasion and metastasis of osteosarcoma.","authors":"Siping Long, Yanxin Zhong, Jiaming Liu","doi":"10.1080/17520363.2024.2366160","DOIUrl":"10.1080/17520363.2024.2366160","url":null,"abstract":"<p><p>Osteosarcoma (OS), a primary human malignant tumor that affects the bones, mostly arises in children and adolescents. Even though surgical resection followed by radiotherapy and chemotherapy has improved the survival rate up to 60%, the long-term positive effect for most patients with OS is not satisfactory. Hence, elucidating the specific mechanisms involved in the pathogenesis of OS is particularly important. Aurora-B, a serine/threonine kinase, plays a crucial role in centrosome regulation, spindle formation and chromosomal separation during mitosis. It has been found that Aurora-B overexpression is related to the occurrence and development of several malignant tumors, including OS. This article summarizes the role of Aurora-B in the invasion and metastasis of OS.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"639-647"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in glaucoma: a meta-analysis. 青光眼中血小板与淋巴细胞比率和淋巴细胞与单核细胞比率:一项荟萃分析。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-02-09 DOI: 10.2217/bmm-2023-0651
Shu-Han Chuang, Cheng-Hsien Chang

Aim: To explore the association between two systemic inflammation markers, platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR), and glaucoma. Materials & methods: The authors searched PubMed, Embase and the Cochrane Library for eligible studies comparing PLR and LMR levels in glaucoma patients and healthy controls. Results: Analysis revealed that glaucoma patients exhibited significantly elevated PLR levels and reduced LMR compared with nonglaucoma controls. These findings were consistent across various glaucoma types, with the exception of secondary glaucoma, where the association with PLR was less significant. Conclusion: The authors found PLR and LMR to be potential valuable biomarkers for glaucoma identification and progression monitoring. These findings highlight the role of systemic inflammation in glaucoma pathogenesis.

目的:探讨血小板-淋巴细胞比值(PLR)和淋巴细胞-单核细胞比值(LMR)这两种全身炎症指标与青光眼之间的关系。材料与方法:作者检索了 PubMed、Embase 和 Cochrane 图书馆中符合条件的研究,比较了青光眼患者和健康对照组的血小板淋巴细胞比和淋巴细胞单核细胞比水平。结果显示分析表明,与非青光眼对照组相比,青光眼患者的 PLR 水平明显升高,LMR 水平明显降低。这些发现在各种类型的青光眼中都是一致的,但继发性青光眼除外,因为继发性青光眼与 PLR 的关系不太明显。结论:作者发现 PLR 和 LMR 是识别青光眼和监测青光眼进展的潜在有价值的生物标志物。这些发现凸显了全身炎症在青光眼发病机制中的作用。
{"title":"Platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in glaucoma: a meta-analysis.","authors":"Shu-Han Chuang, Cheng-Hsien Chang","doi":"10.2217/bmm-2023-0651","DOIUrl":"10.2217/bmm-2023-0651","url":null,"abstract":"<p><p><b>Aim:</b> To explore the association between two systemic inflammation markers, platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR), and glaucoma. <b>Materials & methods:</b> The authors searched PubMed, Embase and the Cochrane Library for eligible studies comparing PLR and LMR levels in glaucoma patients and healthy controls. <b>Results:</b> Analysis revealed that glaucoma patients exhibited significantly elevated PLR levels and reduced LMR compared with nonglaucoma controls. These findings were consistent across various glaucoma types, with the exception of secondary glaucoma, where the association with PLR was less significant. <b>Conclusion:</b> The authors found PLR and LMR to be potential valuable biomarkers for glaucoma identification and progression monitoring. These findings highlight the role of systemic inflammation in glaucoma pathogenesis.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"39-49"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139706086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PRAMEF12, a novel cancer/testis gene, regulates proliferation and apoptosis to promote progression of glioma. PRAMEF12 是一种新型癌/睾丸基因,它能调节胶质瘤的增殖和凋亡,从而促进胶质瘤的发展。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-06-24 DOI: 10.2217/bmm-2023-0219
Jiaqiang Li, Jianhua Zhong, Aifa Tang, Jianchun Yin, Shoulin Li

Aim: To evaluate whether PRAMEF12 can serve as a diagnostic biomarker for glioma. Methods: We examined PRAMEF12 expression in multiple normal and glioma tissues. The diagnostic value of PRAMEF12 was evaluated using receiver operating characteristic curve analysis. The effect of PRAMEF12 ablation on proliferation, cell cycle and apoptosis was investigated. Database analyses were utilized for functional enrichment analysis. Results: PRAMEF12 expression in normal tissue was restricted to the human testis. PRAMEF12 displayed significant diagnostic value in glioma. PRAMEF12 knockdown inhibited cell proliferation, induced apoptosis and resulted in induction of S-phase cell cycle arrest. Pathway enrichment analysis indicated that PRAMEF12 may participate in cancer. Conclusion: PRAMEF12, a novel cancer/testis gene, may be a potential new diagnostic biomarker for glioma.

目的:评估 PRAMEF12 是否可作为胶质瘤的诊断生物标记物。方法: 我们检测了 PRAMEF12 在多个正常组织和胶质瘤组织中的表达:我们检测了PRAMEF12在多个正常组织和胶质瘤组织中的表达。使用接收者操作特征曲线分析评估了 PRAMEF12 的诊断价值。研究了 PRAMEF12 消减对增殖、细胞周期和细胞凋亡的影响。利用数据库分析进行了功能富集分析。结果正常组织中 PRAMEF12 的表达仅限于人类睾丸。PRAMEF12 在胶质瘤中有重要的诊断价值。PRAMEF12 基因敲除可抑制细胞增殖、诱导细胞凋亡并导致细胞周期S期停滞。通路富集分析表明,PRAMEF12 可能参与了癌症的发生。结论PRAMEF12是一种新型癌症/睾丸癌基因,可能是胶质瘤的一种潜在的新诊断生物标记物。
{"title":"<i>PRAMEF12</i>, a novel cancer/testis gene, regulates proliferation and apoptosis to promote progression of glioma.","authors":"Jiaqiang Li, Jianhua Zhong, Aifa Tang, Jianchun Yin, Shoulin Li","doi":"10.2217/bmm-2023-0219","DOIUrl":"10.2217/bmm-2023-0219","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate whether <i>PRAMEF12</i> can serve as a diagnostic biomarker for glioma. <b>Methods:</b> We examined <i>PRAMEF12</i> expression in multiple normal and glioma tissues. The diagnostic value of <i>PRAMEF12</i> was evaluated using receiver operating characteristic curve analysis. The effect of <i>PRAMEF12</i> ablation on proliferation, cell cycle and apoptosis was investigated. Database analyses were utilized for functional enrichment analysis. <b>Results:</b> <i>PRAMEF12</i> expression in normal tissue was restricted to the human testis. <i>PRAMEF12</i> displayed significant diagnostic value in glioma. <i>PRAMEF12</i> knockdown inhibited cell proliferation, induced apoptosis and resulted in induction of S-phase cell cycle arrest. Pathway enrichment analysis indicated that <i>PRAMEF12</i> may participate in cancer. <b>Conclusion:</b> <i>PRAMEF12</i>, a novel cancer/testis gene, may be a potential new diagnostic biomarker for glioma.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"385-397"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11285353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel metabolic biomarkers for the diagnosis of acute ischemic stroke. 用于诊断急性缺血性中风的新型代谢生物标记物。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-09-05 DOI: 10.1080/17520363.2024.2389033
Zhenzhen Tang, Baoli Xu, Junjun Wang, Wenzhen Wang, Shanshan Sha, Yongjin Sun

Aim: To identify novel metabolic biomarkers for patients with acute ischemic stroke (AIS).Methods: The metabolites in the sera of 63 patients with AIS aged 45∼77 years and 60 healthy individuals were analyzed by liquid chromatography (LC)-mass spectrometry (MS)/MS. The efficiency of significantly altered metabolites as biomarkers of AIS was evaluated by ROC curve analysis.Results: Different metabolic profiles were revealed in AIS patients' sera compared with healthy persons. Twelve significantly altered metabolites had an area under the curve (AUC) value >0.80, demonstrating their potential as a biomarker of AIS. Among them, six metabolites are firstly reported to distinguish between AIS patients and healthy individuals.Conclusion: These 12 metabolites can be further researched as potential diagnostic biomarkers of AIS.

目的:确定急性缺血性脑卒中(AIS)患者的新型代谢生物标志物:方法:采用液相色谱法(LC)-质谱法(MS)/质谱法(MS)分析了63名年龄在45∼77岁之间的AIS患者和60名健康人血清中的代谢物。通过 ROC 曲线分析评估了明显改变的代谢物作为 AIS 生物标志物的效率:结果:与健康人相比,AIS 患者血清中的代谢特征有所不同。12种明显改变的代谢物的曲线下面积(AUC)值大于0.80,表明它们具有作为AIS生物标志物的潜力。结论:这 12 个代谢物可作为 AIS 的生物标志物:结论:这12种代谢物可作为AIS的潜在诊断生物标志物进行进一步研究。
{"title":"Novel metabolic biomarkers for the diagnosis of acute ischemic stroke.","authors":"Zhenzhen Tang, Baoli Xu, Junjun Wang, Wenzhen Wang, Shanshan Sha, Yongjin Sun","doi":"10.1080/17520363.2024.2389033","DOIUrl":"10.1080/17520363.2024.2389033","url":null,"abstract":"<p><p><b>Aim:</b> To identify novel metabolic biomarkers for patients with acute ischemic stroke (AIS).<b>Methods:</b> The metabolites in the sera of 63 patients with AIS aged 45∼77 years and 60 healthy individuals were analyzed by liquid chromatography (LC)-mass spectrometry (MS)/MS. The efficiency of significantly altered metabolites as biomarkers of AIS was evaluated by ROC curve analysis.<b>Results:</b> Different metabolic profiles were revealed in AIS patients' sera compared with healthy persons. Twelve significantly altered metabolites had an area under the curve (AUC) value >0.80, demonstrating their potential as a biomarker of AIS. Among them, six metabolites are firstly reported to distinguish between AIS patients and healthy individuals.<b>Conclusion:</b> These 12 metabolites can be further researched as potential diagnostic biomarkers of AIS.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"727-737"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142131831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspective: metabolomics has the potential to change the landscape of kidney transplantation diagnostics. 视角:代谢组学有可能改变肾移植诊断的格局。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-09-05 DOI: 10.1080/17520363.2024.2394383
Dirk R J Kuypers, Jurre J Kamphorst, Henriette de Loor, Elizabeth M O'Day

Kidney transplantation is the most efficient renal replacement therapy. Current diagnostics for monitoring graft health are either invasive or lack precision. Metabolomics is an emerging discipline focused on the analysis of the small molecules involved in metabolism. Given the kidneys' central role in metabolic homeostasis and previous observations of altered metabolites correlating with restricted kidney graft function, metabolomics is highly promising for the discovery of novel biomarkers and the development of novel diagnostics. In this perspective, we summarize the known metabolic roles for the kidney, discuss biomarkers of graft health and immune status emerging from metabolomics research, and provide our perspective on how these and future findings can be integrated in clinical practice to enable precision diagnostics.

肾移植是最有效的肾脏替代疗法。目前用于监测移植物健康状况的诊断方法要么具有侵入性,要么缺乏精确性。代谢组学是一门新兴学科,重点分析参与新陈代谢的小分子。鉴于肾脏在新陈代谢平衡中的核心作用,以及之前观察到的代谢物改变与肾移植功能受限的相关性,代谢组学在发现新型生物标记物和开发新型诊断方法方面大有可为。在本视角中,我们总结了已知的肾脏代谢作用,讨论了代谢组学研究中出现的移植物健康和免疫状态的生物标志物,并就如何将这些发现和未来的发现融入临床实践以实现精准诊断提供了我们的观点。
{"title":"Perspective: metabolomics has the potential to change the landscape of kidney transplantation diagnostics.","authors":"Dirk R J Kuypers, Jurre J Kamphorst, Henriette de Loor, Elizabeth M O'Day","doi":"10.1080/17520363.2024.2394383","DOIUrl":"10.1080/17520363.2024.2394383","url":null,"abstract":"<p><p>Kidney transplantation is the most efficient renal replacement therapy. Current diagnostics for monitoring graft health are either invasive or lack precision. Metabolomics is an emerging discipline focused on the analysis of the small molecules involved in metabolism. Given the kidneys' central role in metabolic homeostasis and previous observations of altered metabolites correlating with restricted kidney graft function, metabolomics is highly promising for the discovery of novel biomarkers and the development of novel diagnostics. In this perspective, we summarize the known metabolic roles for the kidney, discuss biomarkers of graft health and immune status emerging from metabolomics research, and provide our perspective on how these and future findings can be integrated in clinical practice to enable precision diagnostics.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"787-794"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142131832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Naples prognostic score to predict long-term mortality in patients with pulmonary embolism. 评估预测肺栓塞患者长期死亡率的那不勒斯预后评分。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-03-15 DOI: 10.2217/bmm-2023-0741
Levent Pay, Tuğba Çetin, Kıvanç Keskin, Şeyda Dereli, Ozan Tezen, Ahmet Ç Yumurtaş, Zeynep Kolak, Semih Eren, Faysal Şaylık, Tufan Çınar, Mert I Hayıroğlu

Background: The Naples prognostic score (NPS), which reflects the inflammatory and nutritional status of patients, is often used to determine prognosis in cancer patients. The aim of this study was to determine the long-term prognostic value of the NPS in acute pulmonary embolism (APE) patients. Methods: Two hundred thirty-nine patients diagnosed with APE were divided into two groups according to their NPS, and long-term mortality was compared. Results: The long-term mortality was observed in 38 patients out of 293 patients in the mean follow-up of 24 months. Multivariate analysis showed that NPS as a categorical parameter and NPS as a numeric parameter were independent predictors of long-term mortality. Conclusion: This study highlights that NPS may have the potential to predict long-term mortality in APE patients.

背景:那不勒斯预后评分(NPS那不勒斯预后评分(NPS)反映了患者的炎症和营养状况,常用于判断癌症患者的预后。本研究旨在确定那不勒斯预后评分在急性肺栓塞(APE)患者中的长期预后价值。研究方法根据 NPS 将 239 名确诊为 APE 的患者分为两组,并比较其长期死亡率。结果在平均 24 个月的随访中,293 名患者中有 38 人出现长期死亡。多变量分析显示,作为分类参数的 NPS 和作为数值参数的 NPS 是长期死亡率的独立预测因素。结论:本研究强调,NPS 有可能预测 APE 患者的长期死亡率。
{"title":"Evaluation of Naples prognostic score to predict long-term mortality in patients with pulmonary embolism.","authors":"Levent Pay, Tuğba Çetin, Kıvanç Keskin, Şeyda Dereli, Ozan Tezen, Ahmet Ç Yumurtaş, Zeynep Kolak, Semih Eren, Faysal Şaylık, Tufan Çınar, Mert I Hayıroğlu","doi":"10.2217/bmm-2023-0741","DOIUrl":"10.2217/bmm-2023-0741","url":null,"abstract":"<p><p><b>Background:</b> The Naples prognostic score (NPS), which reflects the inflammatory and nutritional status of patients, is often used to determine prognosis in cancer patients. The aim of this study was to determine the long-term prognostic value of the NPS in acute pulmonary embolism (APE) patients. <b>Methods:</b> Two hundred thirty-nine patients diagnosed with APE were divided into two groups according to their NPS, and long-term mortality was compared. <b>Results:</b> The long-term mortality was observed in 38 patients out of 293 patients in the mean follow-up of 24 months. Multivariate analysis showed that NPS as a categorical parameter and NPS as a numeric parameter were independent predictors of long-term mortality. <b>Conclusion:</b> This study highlights that NPS may have the potential to predict long-term mortality in APE patients.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"253-263"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140130743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. 一名接受表皮生长因子受体酪氨酸激酶抑制剂治疗的非小细胞肺癌患者脑干出现非增强、T2流体增强反转恢复高强化、弥散限制性病变。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-05-24 DOI: 10.1080/17520363.2024.2342231
Carlen A Yuen, Silin Bao, Xiao-Tang Kong

Leptomeningeal metastasis (LM) is a devastating complication of malignancy. Diagnosis relies on both contrast enhancement on imaging and malignant cells in cerebral spinal fluid cytology. Though early detection and prompt intervention improves survival, the detection of LM is limited by false negatives. A rare brainstem imaging finding uncovered specifically in EGFR mutation-positive lung cancer patients may represent an early sign of LM. This sign demonstrates high signal on T2 fluid-attenuated inversion recovery and diffusion-weighted imaging sequences, but paradoxically lacks correlative contrast enhancement. Here we report a case of a 72-year-old female EGFR-positive lung cancer patient who developed this lesion following treatment with two first-generation EGFR tyrosine kinase inhibitors then showed subsequent response to osimertinib, an irreversible third-generation EGFR tyrosine kinase inhibitor.

脑膜转移(LM)是恶性肿瘤的一种破坏性并发症。诊断依赖于造影剂的对比增强和脑脊液细胞学检查中的恶性细胞。虽然早期发现和及时干预能提高生存率,但 LM 的检测受到假阴性的限制。在表皮生长因子受体突变阳性的肺癌患者中发现的一种罕见的脑干成像发现可能是肺癌的早期征兆。该征象在 T2 液体减弱反转恢复和弥散加权成像序列上表现为高信号,但奇怪的是缺乏相关的对比度增强。在此,我们报告了一例72岁的女性表皮生长因子受体(EGFR)阳性肺癌患者,她在接受两种第一代EGFR酪氨酸激酶抑制剂治疗后出现了这种病变,随后对不可逆的第三代EGFR酪氨酸激酶抑制剂奥希替尼产生了反应。
{"title":"A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient.","authors":"Carlen A Yuen, Silin Bao, Xiao-Tang Kong","doi":"10.1080/17520363.2024.2342231","DOIUrl":"10.1080/17520363.2024.2342231","url":null,"abstract":"<p><p>Leptomeningeal metastasis (LM) is a devastating complication of malignancy. Diagnosis relies on both contrast enhancement on imaging and malignant cells in cerebral spinal fluid cytology. Though early detection and prompt intervention improves survival, the detection of LM is limited by false negatives. A rare brainstem imaging finding uncovered specifically in <i>EGFR</i> mutation-positive lung cancer patients may represent an early sign of LM. This sign demonstrates high signal on T2 fluid-attenuated inversion recovery and diffusion-weighted imaging sequences, but paradoxically lacks correlative contrast enhancement. Here we report a case of a 72-year-old female <i>EGFR</i>-positive lung cancer patient who developed this lesion following treatment with two first-generation <i>EGFR</i> tyrosine kinase inhibitors then showed subsequent response to osimertinib, an irreversible third-generation <i>EGFR</i> tyrosine kinase inhibitor.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"18 9","pages":"431-439"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11285344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141615899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linkage of serum ITIH4 with Th2 signature cytokine, inflammation, exacerbation risk and severity in childhood asthma. 血清 ITIH4 与儿童哮喘的 Th2 特征细胞因子、炎症、恶化风险和严重程度之间的联系。
IF 1.9 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-01-01 Epub Date: 2024-07-16 DOI: 10.1080/17520363.2024.2366149
Weina Li, Xiaoxue Wang, Hong An

Aim: ITIH4 has anti-inflammatory properties toward eosinophilic/neutrophilic inflammation. This study aimed to explore clinical value of ITIH4 in childhood asthma.Materials & methods: Serum ITIH4 and inflammatory cytokines were determined in 120 childhood asthma patients by enzyme-linked immunosorbent assay.Results: In the entire and acute exacerbation patients, ITIH4 positively associated with IFN-γ, but negatively related to proinflammatory cytokines. ITIH4 was lowest in patients with acute exacerbation, followed by chronic persistent, and highest in clinical remission. By receiver-operating characteristic analysis, ITIH4 potentially estimated acute exacerbation asthma risk. Moreover, ITIH4 negatively related to exacerbation severity in acute exacerbation patients.Conclusion: Serum ITIH4 negatively links with Th2 cell signature cytokine, proinflammatory cytokines, exacerbation risk and severity in childhood asthma.

目的:ITIH4 对嗜酸性粒细胞/中性粒细胞炎症具有抗炎特性。本研究旨在探讨 ITIH4 在儿童哮喘中的临床价值。材料与方法:采用酶联免疫吸附法测定 120 名儿童哮喘患者的血清 ITIH4 和炎症细胞因子。结果在全部患者和急性加重期患者中,ITIH4 与 IFN-γ 呈正相关,但与促炎细胞因子呈负相关。急性加重期患者的 ITIH4 最低,慢性持续期患者次之,临床缓解期患者最高。通过受体运算特征分析,ITIH4 有可能估算出哮喘急性加重的风险。此外,ITIH4 与急性加重期患者的加重严重程度呈负相关。结论血清 ITIH4 与 Th2 细胞特征细胞因子、促炎细胞因子、儿童哮喘的恶化风险和严重程度呈负相关。
{"title":"Linkage of serum ITIH4 with Th2 signature cytokine, inflammation, exacerbation risk and severity in childhood asthma.","authors":"Weina Li, Xiaoxue Wang, Hong An","doi":"10.1080/17520363.2024.2366149","DOIUrl":"10.1080/17520363.2024.2366149","url":null,"abstract":"<p><p><b>Aim:</b> ITIH4 has anti-inflammatory properties toward eosinophilic/neutrophilic inflammation. This study aimed to explore clinical value of ITIH4 in childhood asthma.<b>Materials & methods:</b> Serum ITIH4 and inflammatory cytokines were determined in 120 childhood asthma patients by enzyme-linked immunosorbent assay.<b>Results:</b> In the entire and acute exacerbation patients, ITIH4 positively associated with IFN-γ, but negatively related to proinflammatory cytokines. ITIH4 was lowest in patients with acute exacerbation, followed by chronic persistent, and highest in clinical remission. By receiver-operating characteristic analysis, ITIH4 potentially estimated acute exacerbation asthma risk. Moreover, ITIH4 negatively related to exacerbation severity in acute exacerbation patients.<b>Conclusion:</b> Serum ITIH4 negatively links with Th2 cell signature cytokine, proinflammatory cytokines, exacerbation risk and severity in childhood asthma.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"593-602"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomarkers in medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1